Literature DB >> 16163444

IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes.

S Ryu1, J H Lee, S I Kim.   

Abstract

Interleukin-17 (IL-17) is a proinflammatory cytokine that is expressed in the synovium T cells of rheumatoid arthritis (RA). This cytokine is implicated in the inflammation and destruction of the joint. However, the role of IL-17 on the production of vascular endothelial factor (VEGF) important to synovial proliferation has still not been identified. In this study, we investigated the effect on cultured rheumatoid fibroblast-like synoviocytes (FLS) of the IL-17 on the production and expression of VEGF, which play an important role in angiogenesis in rheumatoid synovium. IL-17 increased the production of VEGF dose dependently and the mRNA expression of VEGF. These results suggest that IL-17 might influence angiogenesis in RA by up-regulating the expression of VEGF in rheumatoid FLS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163444     DOI: 10.1007/s10067-005-1081-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  39 in total

1.  Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes.

Authors:  Y Katz; O Nadiv; Y Beer
Journal:  Arthritis Rheum       Date:  2001-09

2.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.

Authors:  D V Jovanovic; J A Di Battista; J Martel-Pelletier; F C Jolicoeur; Y He; M Zhang; F Mineau; J P Pelletier
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

3.  Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

Authors:  B Berse; J A Hunt; R J Diegel; P Morganelli; K Yeo; F Brown; R A Fava
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

Authors:  E Tartour; F Fossiez; I Joyeux; A Galinha; A Gey; E Claret; X Sastre-Garau; J Couturier; V Mosseri; V Vives; J Banchereau; W H Fridman; J Wijdenes; S Lebecque; C Sautès-Fridman
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

5.  Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.

Authors:  E Lubberts; L A Joosten; F A van de Loo; L A van den Gersselaar; W B van den Berg
Journal:  Arthritis Rheum       Date:  2000-06

6.  Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.

Authors:  J-M Kim; S-H Ho; W Hahn; J-G Jeong; E-J Park; H-J Lee; S S Yu; C-S Lee; Y-W Lee; S Kim
Journal:  Gene Ther       Date:  2003-08       Impact factor: 5.250

7.  Increased urinary excretion of interleukin-17 in nephrotic patients.

Authors:  Koichi Matsumoto; Katsuo Kanmatsuse
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

8.  Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Authors:  Erik Lubberts; Marije I Koenders; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Christina J J Coenen-de Roo; Leo A B Joosten; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2004-02

9.  Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

Authors:  E M Paleolog; S Young; A C Stark; R V McCloskey; M Feldmann; R N Maini
Journal:  Arthritis Rheum       Date:  1998-07

10.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Authors:  R A Fava; N J Olsen; G Spencer-Green; K T Yeo; T K Yeo; B Berse; R W Jackman; D R Senger; H F Dvorak; L F Brown
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  36 in total

Review 1.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Expanded role for interleukin-17 in rheumatoid arthritis.

Authors:  Feng-Lai Yuan; Xia Li; Cheng-Wan Li; Rui-Sheng Xu; Jun-Ming Sun
Journal:  Clin Rheumatol       Date:  2011-10-04       Impact factor: 2.980

3.  IL-17 contributes to angiogenesis in rheumatoid arthritis.

Authors:  Sarah R Pickens; Michael V Volin; Arthur M Mandelin; Jay K Kolls; Richard M Pope; Shiva Shahrara
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

Review 4.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

5.  Role of TH-17 cells in rheumatic and other autoimmune diseases.

Authors:  Michael V Volin; Shiva Shahrara
Journal:  Rheumatology (Sunnyvale)       Date:  2011-10-20

6.  IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.

Authors:  Amol Suryawanshi; Tamara Veiga-Parga; Pradeep B J Reddy; Naveen K Rajasagi; Barry T Rouse
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

Review 7.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

Review 8.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

Review 9.  Breaking old paradigms: Th17 cells in autoimmune arthritis.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-04-28       Impact factor: 3.969

Review 10.  Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.

Authors:  Seung-Ah Yoo; Seung-Ki Kwok; Wan-Uk Kim
Journal:  Mediators Inflamm       Date:  2009-02-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.